The Ezetimibe Market is witnessing significant growth, driven by the rising global burden of hypercholesterolemia and cardiovascular diseases. As public health strategies increasingly focus on managing lipid disorders, ezetimibe—an effective cholesterol absorption inhibitor—continues to gain traction in both monotherapy and combination therapies.
With a mechanism targeting...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek